Skip to main content

Table 1 Comparison of the concordance index among RSF models

From: Whole-genome sequencing identifies novel predictors for hematopoietic cell transplant outcomes for patients with myelodysplastic syndrome: a CIBMTR study

Survival model/concordance (95%CI)

OS

DFS

Relapse

TRM

Base model

0.49 (0.44–0.52)

0.48 (0.43–0.50)

0.45 (0.39–0.50)

0.45 (0.37–0.50)

Clinical model

0.54 (0.53–0.60)

0.55 (0.51–0.58)

0.55 (0.50–0.60)

0.54 (0.48–0.59)

Genomic model

0.83 (0.81–0.85)

0.75 (0.73–0.77)

0.80 (0.77–0.82)

0.80 (0.78–0.83)

Full model

0.84 (0.83–0.86)

0.78 (0.76–0.81)

0.73 (0.70–0.77)

0.85 (0.82–0.87)

Full model (regimen = myeloablative)

0.83 (0.80–0.86)

0.79 (0.75–0.83)

0.75 (0.69–0.81)

0.85 (0.80–0.90)

Full model (regimen = reduced intensity)

0.83 (0.80–0.85)

0.79 (0.76–0.81)

0.77 (0.74–0.80)

0.84 (0.82–0.87)

  1. Base model: IPSS-R
  2. Clinical model: Base model + mdstype + HMA + CHEMO
  3. Genomic model: genomic association candidates + genomic clustering subgroups
  4. Full model: Clinical model + Genomic model